Advertisements

Alopurinol

Quick links to important sections

Alopurinol

Advertisements

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Alopurinol

What is Allopurinol?

Allopurinol is a pharmacological agent primarily used to manage high levels of uric acid in the body. It belongs to a class of medications known as xanthine oxidase inhibitors. By targeting the enzyme responsible for the production of uric acid, allopurinol helps to lower the concentration of this substance in the blood and urine.

Mechanism of Action

The body produces uric acid as a byproduct of breaking down purines, which are natural substances found in the body's cells and in certain foods. When uric acid levels become excessive—a condition known as hyperuricemia—it can lead to the formation of sharp, needle-like crystals in the joints or kidneys.

Allopurinol works by blocking the activity of xanthine oxidase. This enzyme is essential for the final steps of uric acid synthesis. By inhibiting this process, the medication reduces the overall production of uric acid, which prevents the accumulation of crystals and assists in the gradual dissolution of existing deposits.

Primary Uses

Allopurinol is typically utilized in the management of chronic conditions associated with elevated uric acid. Its clinical applications include:

  • Gout Management: It is used as a long-term preventative measure to reduce the frequency of gout attacks and prevent joint damage by maintaining low uric acid levels.
  • Kidney Stone Prevention: For individuals prone to specific types of kidney stones, such as calcium oxalate stones or uric acid stones, allopurinol helps reduce the likelihood of stone formation.
  • Secondary Hyperuricemia: It is sometimes employed when other medical treatments or underlying conditions cause a significant rise in uric acid levels, such as during certain oncological therapies that lead to rapid cell breakdown.

Regulatory References

  1. Allopurinol: MedlinePlus Drug Information - NIH
Advertisements

What side effects are possible with Alopurinol?

Possible Side Effects and Safety Information

Adverse Reaction Categories

Alopurinol has a well-documented safety profile, with the most significant risk being severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). These reactions are rare but can be fatal and typically occur early in therapy. Other serious reactions include hepatotoxicity (liver damage), myelosuppression (bone marrow suppression), and effects on the renal system.

Commonly reported adverse reactions (incidence >1%) include skin rash, nausea, diarrhea, and initial acute gout flares. Drowsiness and dizziness have also been reported.

Safety Restrictions and Monitoring

Therapy should be immediately and permanently discontinued at the first appearance of a skin rash or any sign of a hypersensitivity reaction. Caution is required in specific patient populations:

  • Renal Impairment: Lower doses are mandatory for patients with decreased kidney function, as this condition increases the risk of severe hypersensitivity reactions and accumulation of the drug and its metabolites.
  • *Genetic Risk (HLA-B58:01):* Patients of certain Asian descents (e.g., Han Chinese, Korean, Thai) have a significantly higher risk of SCARs due to the presence of the HLA-B58:01 genetic marker, and screening may be recommended. The drug is generally not recommended in these patients unless the benefits outweigh the risks.
  • Monitoring: Regular monitoring of kidney and liver function is advised, particularly during the initial phases of treatment. Patients should be cautioned regarding the potential for drowsiness, which may impair the ability to operate machinery or drive.
Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Allopurinol overdose details specific acute manifestations and the risk of severe systemic complications.

Documented Manifestations and Severe Outcomes

Massive acute overdosage is associated with the potential for xanthine crystalluria, a physiological finding that may precipitate acute renal failure due to the accumulation and precipitation of xanthine in the renal tubules. While clinical signs from massive ingestion are not commonly reported, the regulatory labels emphasize the critical risk of life-threatening systemic reactions. These reactions, which can occur with overexposure, include Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and irreversible hepatotoxicity. These are the most severe outcomes linked to Allopurinol Hypersensitivity Syndrome.


Required Emergency Actions

Management of overdosage is strictly symptomatic and supportive, as no specific antidote is documented in the prescribing information. Hemodialysis is listed as a potential procedural measure that may be utilized to remove Allopurinol and its active metabolite, oxipurinol. The official guidance mandates that patients seek immediate medical attention and discontinue the drug immediately upon the first appearance of a skin rash or other signs indicative of a severe hypersensitivity reaction. The risk of toxicity is a particular concern in patients with impaired renal function due to reduced drug clearance.

Advertisements

Therapeutic Uses of Alopurinol

What Allopurinol Treats: Main Uses and Benefits

This medication is generally used to help manage symptoms that create noticeable physiological strain. It is applied across therapeutic domains where additional symptomatic support is needed for conditions involving episodic or fluctuating manifestations, such as chronic gout, the management of high uric acid levels during certain cancer treatments, and the support for uric acid kidney issues.

The core benefit is that this chronic therapy assists with maintaining functional stability and contributes to easing the overall symptom load. This support helps the patient cope more steadily with difficult episodes and may assist with a reduction in the recurrence of acute, painful attacks, including the management of chronic joint manifestations. In clinical settings that involve heightened systemic burden, the treatment also plays a role in managing high uric acid levels, supporting the patient during difficult episodes by easing distress.


Quick Fact: Supportive Management for Related Symptoms

Domain Therapeutic Benefit
Gout Supports stability by contributing to a reduction in the recurrence of acute, painful joint attacks.
Kidney Assists with management of discomfort by helping address uric acid stone formation.
Oncology Contributes to maintaining functional stability during high-risk treatment phases.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

The eligibility for allopurinol is defined by regulatory agencies based on patient history, age, organ function, and specific clinical status. Use is restricted or contraindicated for several populations as stated in official labeling.

Populations For Whom Use Is Contraindicated

  • Individuals with a documented history of severe allergic reaction or hypersensitivity to allopurinol or any component of the formulation.
  • Initiation of therapy is contraindicated during an acute gout attack.

Conditional Eligibility and Restrictions

Category Regulatory Status Official Restriction Details
Organ Function Conditional Use Patients with impaired renal or hepatic function must use the medicine with caution, as dose reduction and monitoring are required due to the body’s processing of the drug.
Age Groups Restricted/Caution Pediatric use is generally not recommended except for specific indications like hyperuricemia secondary to cancer treatment. Older adults require caution due to the higher likelihood of reduced renal function.
Reproductive Status Not Recommended Use is not recommended during pregnancy unless the benefit clearly outweighs the documented risk. The medicine is also not recommended for breastfeeding mothers.
Comorbidities Restricted Patients with a positive *HLA-B58:01 allele** (relevant in certain Asian populations) face a high risk of severe skin reactions, restricting use unless benefits clearly justify the risk.

The regulatory profile strictly establishes that the medicine is not recommended for treating asymptomatic hyperuricemia alone, restricting eligibility solely to specific symptomatic or high-risk conditions.

Advertisements

What should I know about interactions with other medicines?

Alopurinol can interact with several other medications, potentially increasing the risk of side effects or altering the effects of one or both drugs. It is crucial to inform your healthcare provider about all prescription, over-the-counter (OTC) medicines, and supplements you are taking.

Major Interactions

Concomitant Medicine Potential Interaction
Azathioprine or Mercaptopurine Alopurinol inhibits the enzyme that metabolizes these drugs, leading to significantly increased levels and a high risk of severe bone marrow suppression (low blood cell counts). The dose of azathioprine or mercaptopurine must be drastically reduced (often to 25% of the usual dose) with close monitoring.
Warfarin (blood thinner) Alopurinol may enhance the anticoagulant effect of warfarin, increasing the risk of bleeding. Closer monitoring of blood clotting tests (INR) and a possible warfarin dose adjustment are required.
Didanosine Increased levels of didanosine can occur, which may increase the risk of side effects. Co-administration is generally not recommended.
Theophylline Alopurinol can inhibit the metabolism of theophylline, leading to increased plasma levels and toxicity.

Increased Risk of Hypersensitivity/Rash

Concomitant use of alopurinol with Ampicillin or Amoxicillin may increase the risk of skin rash. Also, certain blood pressure medications, specifically Angiotensin-Converting Enzyme (ACE) inhibitors (like Enalapril or Captopril) and Thiazide diuretics (like Hydrochlorothiazide), can increase the risk of severe hypersensitivity reactions to alopurinol, especially in patients with impaired kidney function.

Separately, Aluminum Hydroxide-containing antacids may reduce the effect of alopurinol if taken simultaneously, so a time separation (e.g., three hours) between doses is often advised. There are no known significant interactions between alopurinol and food or non-alcoholic beverages.

Advertisements

Mechanism of Action

Enzyme Inhibition of Xanthine Oxidase

The core mechanism is the consistent and long-lasting inhibition of the Xanthine Oxidase (XO) enzyme, achieved primarily by Allopurinol’s active metabolite, Oxypurinol. By binding tightly to the XO enzyme, the drug restricts the conversion of purine precursors into uric acid, thereby achieving suppression of its synthesis.

Catabolite Re-routing and Systemic Clearance

Inhibition of XO leads to a metabolic shift where the intermediate precursors, Hypoxanthine and Xanthine, accumulate upstream instead of being fully converted. Since these precursors are more soluble than uric acid, their increased systemic levels promote renal excretion, contributing to the overall systemic reduction of the purine catabolite load.

Sustained Modulation of Total Urate Pool

This combined effect of suppressing production and facilitating precursor clearance allows the drug to provide sustained modulation that results in a measurable decrease in the total body urate pool. This continuous lowering of serum uric acid concentration below the physiological saturation point creates a regulated, sub-saturation urate state within tissues.

Advertisements

Dosage and Administration Information

How to Use Allopurinol: Official Administration Guidelines

Allopurinol is used according to specific instructions outlined in official regulatory documents, ensuring correct administration as a urate-lowering therapy. The drug is available primarily as an oral tablet for long-term use, but an injectable solution (IV) is approved for patients who cannot tolerate oral intake or require treatment for acute hyperuricemia, such as during certain malignancy treatments.


Standard Dosage and Administration

The standard approach for initiating therapy in chronic gout involves starting with a low oral dose, typically 100 mg once daily for adults. The dose is then gradually adjusted in 100 mg increments, usually on a weekly basis, until the target serum urate level is achieved. Maintenance doses typically range between 200 mg and 300 mg daily, with a maximum dose generally limited to 800 mg to 900 mg per day, depending on regional guidelines.

Administration Principle Official Instruction
Timing & Food Oral tablets should be taken with or immediately after food to minimize gastrointestinal irritation.
Frequency Doses up to 300 mg are generally taken once daily. Higher daily doses are advised to be taken in divided doses.
Fluid Intake Patients must maintain adequate hydration (fluid intake) throughout treatment to promote urinary output.

Population-Specific Adjustments

Dose reduction is mandatory for patients with impaired kidney function, as the drug and its active metabolite, oxipurinol, are primarily eliminated by the kidneys. Older adults should also be administered the lowest effective dosage due to the higher likelihood of reduced renal function.

IV administration requires careful reconstitution and dilution of the powder for injection before it is administered via infusion, often over divided intervals when used for malignancy-associated hyperuricemia.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Allopurinol

The research evidence for Allopurinol is documented in official regulatory summaries and peer-reviewed scientific literature, focusing on research that has explored the observation of patterns in conditions associated with high uric acid levels. Studies include randomized controlled trials (RCTs), systematic reviews, and large observational studies, all aimed at describing the patterns observed in the measured outcomes when the medicine was used in specific patient groups.


Evidence for Use in Chronic Gout

Research where Allopurinol was studied for chronic gout has been conducted across various short-term randomized controlled trials and long-term observational cohort studies. These studies primarily examined outcomes related to systemic urate levels and daily functioning or activity level. Researchers monitored the proportion of patients who achieved a specific target level of serum urate, a key biomarker in gout. Findings describe patterns observed in the studies related to serum urate control, with many populations reporting measurements that indicate a shift toward lower serum urate levels. What remains uncertain includes aspects of long-term outcomes, as core efficacy trials were often not long enough to assess these endpoints fully.


Evidence for Use in Cancer Therapy

Allopurinol was evaluated in clinical trials for its use in patients receiving chemotherapy who are at risk of temporary physiological imbalance due to rapid cell breakdown. This research examined the short-term outcomes in adult and pediatric populations with malignancies. Findings indicate patterns related to the stabilization or measured changes in elevated serum uric acid levels around the time of chemotherapy. The primary uncertainty here is that the follow-up durations were limited (often only a few days), meaning there is limited information for long-term outcomes beyond the acute phase of chemotherapy risk.


Evidence for Use in Recurrent Kidney Stones

Allopurinol was studied for the prevention of recurrent calcium oxalate kidney stones, but only in a specific population: those with documented hyperuricosuria. These trials examined outcomes such as the amount of uric acid excreted in the urine and the rate at which new stones formed. Key limitations include that the results apply only to the populations studied—specifically, individuals with hyperuricosuria who have a history of stone formation. Comparative evidence is lacking for patients without this specific condition.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Alopurinol (FAQ)


Q: How long does it usually take for Alopurinol to start lowering uric acid levels?

The maximum concentration of the active form of the medicine, Oxypurinol, is typically reached in about 4.5 hours after a single dose, according to pharmacokinetic data. However, the full urate-lowering effect may require several weeks of treatment to be measurable.

Q: Is Alopurinol a medicine that generally needs to be taken for the long term or permanently?

Patient information sheets often describe Alopurinol as a long-term or lifelong treatment. Its primary purpose is to maintain consistently lowered urate levels, which is generally used to help prevent the recurrence of gout attacks over time.

Q: Can I take Alopurinol if I am already taking over-the-counter pain medications like ibuprofen?

Regulatory patient information states that concurrent use with common over-the-counter pain relievers like ibuprofen and paracetamol is generally not reported to be an issue. This information should be reviewed with a healthcare provider.

Q: Is it generally advised to limit or avoid alcohol consumption while taking Alopurinol?

Official guidance indicates that limiting or avoiding alcohol consumption is advised during therapy. This is based on the fact that alcohol is known to increase uric acid levels in the blood and may compromise the effect of the medicine.

Q: Why do some users report an increase in gout attacks when they first start taking Alopurinol?

Official prescribing information notes that initiating therapy may sometimes precipitate acute gouty arthritis (a flare) during the early stages of treatment. This reaction is observed as the process of lowering uric acid begins, and it is mentioned that it may take several weeks for the full benefit to be noticed.

Q: What kind of blood tests are typically required for monitoring while taking Allopurinol?

Regulatory documents state that regular monitoring of key systems is required during treatment. This typically includes blood tests to check renal (kidney) and hepatic (liver) function and blood counts, in addition to testing the serum urate levels for dose adjustments.

Q: What are the warning signs of a serious or dangerous allergic reaction to Allopurinol?

Official drug safety information describes several severe allergic reactions, listing warning signs that may accompany or precede a rash. These can include fever, chills, flu-like symptoms, sore throat, swollen lymph nodes, and the appearance of ulcers in the mouth or on the lips.

Q: What is the generally accepted target uric acid level when on Allopurinol therapy for gout?

Clinical guidance often cited by authoritative bodies indicates that for most patients with gout, the goal of therapy is to maintain the serum urate level below 6 mg/dL. In cases of severe gout, a physician may aim for a lower level, such as below 5 mg/dL.

Q: What is the risk of developing a severe skin condition like Stevens-Johnson Syndrome (SJS) from Allopurinol?

Official reviews indicate that severe cutaneous adverse reactions (SCARs), which include SJS, are considered rare but potentially fatal. The estimated risks described in clinical consensus documents typically fall within a range of 1 in 250 to 1 in 1000 treated patients.

Q: How frequently is a follow-up blood test needed once the correct dose of Allopurinol is reached?

Clinical practice guidance suggests that once the appropriate dose is stable and the target urate level is achieved, monitoring is continued. Serum urate and renal function are typically recommended to be checked by a healthcare provider every 6 months during maintenance therapy.

Q: Is it possible to have an allergic reaction to Allopurinol even after taking it for months?

Official summaries note that while the most severe skin reactions often occur within the first few weeks or months of therapy, the possibility of developing delayed or late-onset hypersensitivity reactions is acknowledged.

Q: How does Allopurinol work to dissolve tophi (uric acid deposits) in the joints?

The mechanism is described as consistently lowering the concentration of uric acid in the blood plasma below its saturation limits. This reduction in the total body urate pool allows for the potential for gradual dissolution of gout tophi over time.

Q: Are there non-prescription supplements or vitamins that should be avoided while taking Allopurinol?

Regulatory bodies generally advise patients to consult a healthcare professional regarding all complementary medicines, herbal remedies, and supplements. Official product information states there is insufficient information available to confirm whether specific non-prescription items are safe to take with Allopurinol.

Q: Does the time of day I take Allopurinol matter?

Official guidelines state that if the daily amount is up to 300 mg, the medicine is generally taken once daily. For higher amounts, regulatory guidelines indicate the medicine is generally taken in divided doses after food. There is no specific requirement noted for taking it in the morning versus the evening.

Q: Does Allopurinol commonly cause minor side effects like a metallic or strange taste in the mouth?

While not listed as a common side effect, official summaries of adverse reactions mention that taste disturbance has been reported in post-marketing surveillance. This means it is a possible, though less frequent, side effect.

Q: Are there reports of Allopurinol causing hair loss?

Official summaries of adverse drug reactions indicate that hair loss (alopecia) is listed as an uncommon side effect associated with the medicine.

Q: If a single dose of Allopurinol is missed, what is the general guidance on how to proceed?

General guidance suggests that if a dose is missed and there is adequate time, it may be taken when remembered. If it is close to the next scheduled dose, the common advice is to skip the missed dose and resume the regular schedule.

Q: Can taking Allopurinol affect a patient's sleep patterns?

Official adverse reaction summaries report that somnolence (drowsiness) has been noted as a potential side effect. However, specific sleep pattern disturbances such as insomnia are not consistently listed as a common or known side effect in regulatory documents.

Q: Can the initial increase in gout flares when starting Allopurinol be managed with other drugs?

Official prescribing information notes that a gout flare prophylactic agent (such as an anti-inflammatory medicine or Colchicine) may be used to help prevent the initial increase in flares. This is administered concurrently, often for a period of at least one month.

Q: Does taking Allopurinol increase the risk of vision problems or changes?

Official summaries of adverse reactions indicate that vision problems are possible, listing effects such as cataracts or visual impairment as rare side effects.

Q: Can Allopurinol cause changes in mood or lead to depression in some users?

Official adverse reaction summaries, particularly those available from European regulatory bodies, list depression as a rare adverse reaction that has been reported by users.

Advertisements

How should Alopurinol be stored and disposed of?

Storage Requirements

Allopurinol tablets must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The medication requires protection from moisture; therefore, it must be kept in the original container and the container must remain tightly closed when not in use. To ensure safety, allopurinol must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired allopurinol should not be disposed of in household trash or poured down drains or into wastewater. Official instructions specify that the product should be returned to a community pharmacy or disposed of via a drug take-back program. If these options are unavailable, the medicine should be mixed with an unappealing substance, sealed in a container, and then discarded in the trash, according to official guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alopurinol found in:

A-Z Index: